70 results
8-K
EX-99.5
NOTV
Inotiv Inc
21 Sep 21
Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering
5:30pm
exceed our insurance coverage and ability to pay. Any contamination or injury could also damage our reputation, which is critical to obtaining new … suffer diseases that can damage our inventory, harm our reputation, result in decreased sales of our services or research products or result in other
8-K
EX-99.1
NOTV
Inotiv Inc
5 Aug 05
BASi Appoints New Executive VP — Chief Scientific Officer
12:00am
particular background in discovery life sciences and instruments is of great value for us, and his reputation and relationships in our industry
8-K
EX-99.1
NOTV
Inotiv Inc
30 Apr 18
Departure of Directors or Certain Officers
3:07pm
at BASi, commented, “We are thrilled to welcome Dr. Baim to the BASi family and we are confident that his vast experience, reputation for being
8-K
EX-99.2
NOTV
Inotiv Inc
19 Apr 21
Entry into a Material Definitive Agreement
4:50pm
and molecular therapeutics, this combination gives us the ability to support new therapeutic areas. We believe that Bolder BioPATH’s exemplary reputation
8-K
EX-99.1
NOTV
Inotiv Inc
7 May 19
Entry into a Material Definitive Agreement
4:16pm
with the added sites and in-house capabilities of BASi. We are very proud of the accomplishments and reputation of the Gaithersburg Toxicology Services team
8-K
EX-99.1
5zyx84cz
14 Feb 13
BASi Reports First Quarter Net Income of $0.02 Per Share
12:00am
8-K
EX-99.1
9kz 3go9z7rxu81t681t
26 Dec 13
BASi Reports Profitable Fourth Quarter and Fiscal 2013
12:00am
8-K
EX-99.1
kdj0dwbgup1mabl17y
18 Oct 13
BASi Reports Profitable Third Quarter
12:00am
8-K
EX-99.1
qk7a qn6z8u
29 Dec 14
BASi Reports Fourth Quarter and Full Year 2014 Results
12:00am
424B3
jo6mq6
20 Jan 15
Prospectus supplement
12:00am